WebCuriBio/phenolearn-local. This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository. main. Switch branches/tags. Branches Tags. Could not load branches. Nothing to show {{ refName }} default View all branches. Could not load tags. Nothing to show {{ refName }} default. View all tags. WebSeattle, WA-based Curi will gain access to Danas AI/ML-based platforms including PhenoLearn, a deep learning platform for modeling cell and tissue phenotypes; Pulse, an automated platform for contractility analysis of beating cardiomyocytes; and PhenoTox, a deep learning platform for predictive safety pharmacology.
Drug platform developer Curi Bio acquires AI technology provider …
WebJul 6, 2024 · High-content phenotypic screening identifies histone deacetylase and microtubule inhibitors as cardioprotective compounds To identify candidate therapeutics that protect against sarcomere damage, we conducted an unbiased high-content screen using a library of 5500 bioactive compounds. WebImplement PhenoLearn with how-to, Q&A, fixes, code snippets. kandi ratings - Low support, No Bugs, No Vulnerabilities. No License, Build not available. cs.compuserve.home
Curi Bio Acquires Dana Solutions - DistilINFO LifeSciences
WebView PhenoLearn (www.phenolearn.com) location , revenue, industry and description. Find related and similar companies as well as employees by title and much more. WebCuriBio/phenolearn-local. This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository. main. Switch branches/tags. Branches … WebJul 23, 2024 · SEATTLE--(BUSINESS WIRE)--Curi Bio, a leading developer of human iPSC-based platforms for drug discovery, has acquired Dana Solutions, a pioneer in the application of artificial intelligence and machine learning to in vitro cell-based assays. “Curi Bio is developing human-relevant platforms integrating human cells, systems, and data to … cs compatibility\\u0027s